Results
1
1 companies
argenx
Market Cap: €43.2b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€705.60
7D
0.5%
1Y
27.9%